맨위로

The World Leading Biopharmaceutical Company

Expert of Cell Therapeutics
for Brain Diseases
Core
Competency
01
Vision

Biomedical Company with world best technologies

About us →

02
Technologies

To create the most valuable therapy using human stem cells

MSC → NSC →

03
Therapeutics

To offer novel cell therapeutics to patients with brain diseases

Overview →

Newsroom
more →
Press Release
Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cell
img

2024.01.09

Press Release
韓·美 바이오벤처, 신약 후보물질·플랫폼 기술 첫 상호 협력
img

2023.12.19

Press Release
메디노 \'줄기세포 치료제\', 美 FDA 희귀소아질환 의약품 지정
img

2023.12.19

Press Release
메디노, 110억 시리즈C 펀딩...파이프라인 ‘히스템’ 주효
img

2023.11.01

Press Release
줄기세포 치료제 메디노, 110억 투자 유치
img

2023.10.18

Press Release
깊어지는 한-일 제약바이오 교류... 그 뒤편의 서포터즈
img

2023.10.14